Overexpression of NDRG2 can inhibit neuroblastoma cell proliferation through negative regulation by CYR61.

Asian Pac J Cancer Prev

Department of Neurosurgery and Institute for Functional Brain Disorders, Tangdu Hospital, Xi'an, China E-mail :

Published: November 2014

Several recent studies have showed that the n-myc downstream regulated gene 2 (NDRG2) is a new tumor suppressor gene, and that it plays an important role in tumor suppression in several cancers or cancer cell lines. However, few studies focused on its function in neuroblastoma cells. In the present investigation, we demonstrated that NDRG2 overexpression inhibited their proliferation. Using a cDNA microarray, we found that overexpression of NDRG2 inhibited the expression of cysteine-rich protein 61 (CYR61), a proliferation related gene. From our research, CYR61 may partially hinder NDRG2-mediated inhibition of cell proliferation. Overexpression of NDRG2 resulted in accumulation of cells in the G1 phase, which was accompanied by upregulation of p21 and p27 and downregulation of CDK4 and cyclin D1. Taken together, these data indicate that NDRG2 inhibits the proliferation of neuroblastoma cells partially through suppression of CYR61. Our findings offer novel insights into the physiological roles of NDRG2 in neuroblastoma cell proliferation, and NDRG2 may prove to be effective candidate for the treatment of children with neuroblastoma.

Download full-text PDF

Source
http://dx.doi.org/10.7314/apjcp.2014.15.1.239DOI Listing

Publication Analysis

Top Keywords

overexpression ndrg2
12
cell proliferation
12
neuroblastoma cell
8
neuroblastoma cells
8
ndrg2
7
proliferation
6
neuroblastoma
5
overexpression
4
ndrg2 inhibit
4
inhibit neuroblastoma
4

Similar Publications

Ischemic stroke is one main type of cerebrovascular disorders with leading cause of death and disability worldwide. Astrocytes are the only nerve cell type storing glycogen in the brain, which regulate the glucose metabolism and handle the energy supply and survive of neurons. Astrocyte ferroptosis contributes to neuron injury in brain disorders.

View Article and Find Full Text PDF
Article Synopsis
  • * This study focused on the relationship between NDRG1 expression and the progression of glioblastoma (GB), analyzing tumor samples from 41 patients through immunostaining.
  • * Results showed that higher NDRG1 expression was linked to increased tumor cell proliferation and lower survival rates, suggesting that elevated NDRG1 indicates poorer prognosis for GB patients.
View Article and Find Full Text PDF

The protein, N-myc downstream-regulated gene 2 (NDRG2), a tumor suppressor, is significantly decreased or absent in many types of cancer. There is a significant negative correlation between the levels of NDRG2 and the development and progression of cancer tumor recurrence and tumor invasion, in different cancers. In contrast, the and overexpression of the NDRG2 protein decreases the proliferation, growth, adhesion and migration of many types of cancer cells.

View Article and Find Full Text PDF
Article Synopsis
  • * Increasing NDRG2 levels in SCLC cells leads to reduced cell growth and enhanced sensitivity to chemotherapy by inhibiting key signaling pathways (AKT/mTOR) through PTEN activation.
  • * Overall, NDRG2 acts as an inhibitor of SCLC and may serve as a promising target for therapeutic interventions in treating this aggressive cancer type.
View Article and Find Full Text PDF

Cerebral ischemic preconditioning (CIP) has been shown to improve brain ischemic tolerance against subsequent lethal ischemia. Reactive astrocytes play important roles in cerebral ischemia-reperfusion. Recent studies have shown that reactive astrocytes can be polarized into neurotoxic A1 phenotype (C3d) and neuroprotective A2 phenotype (S100A10).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!